Comparative Pharmacology
Head-to-head clinical analysis: NORMOSOL R IN PLASTIC CONTAINER versus SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORMOSOL R IN PLASTIC CONTAINER versus SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER.
NORMOSOL-R IN PLASTIC CONTAINER vs SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Normosol-R is an isotonic crystalloid solution that replaces extracellular fluid volume and electrolytes. It provides sodium, chloride, potassium, magnesium, acetate, and gluconate to maintain acid-base balance and osmotic equilibrium. Acetate and gluconate are metabolized to bicarbonate, providing an alkalinizing effect.
Sodium lactate is a source of bicarbonate precursor. It is metabolized to bicarbonate in the liver, which buffers metabolic acidosis, restoring acid-base balance.
Intravenous infusion; dose determined by electrolyte and fluid requirements; typical adult dose: 250-1000 mL/hour, not to exceed 30 mL/kg/day.
Intravenous infusion: The typical adult dose is 300-500 mL of 1/6 Molar sodium lactate solution (approximately 167 mEq/L each of sodium and lactate, 1 L contains 167 mEq of sodium and lactate) administered as a continuous intravenous infusion at a rate of 0.5-2.5 mL/kg/hour, adjusted based on the severity of acidosis and clinical response. Maximum infusion rate: 2.5 mL/kg/hour.
None Documented
None Documented
Not applicable as a drug; the half-life of infused crystalloid components is distribution-dependent. Sodium and chloride have a terminal half-life of approximately 2-4 hours in healthy adults, reflecting renal clearance. Clinical context: Half-life prolonged in renal impairment.
30–60 minutes for lactate conversion; bicarbonate component determined by CO2 excretion.
Renal excretion of electrolytes and water; no hepatic metabolism. >95% of administered water and electrolytes are excreted renally, with small amounts lost via feces (<2%) and insensible losses.
Primarily renal as bicarbonate and lactate; <5% unchanged.
Category C
Category C
Intravenous Fluid/Electrolyte Solution
Electrolyte Solution